Advertisement
Screener

REGENERON PHARMACEUTICALS, INC. Historic Quarter Change: Foreign Preferred Shares, Reduced

REGENERON PHARMACEUTICALS, INC. historic quarter change: Foreign Preferred Shares, Reduced

In preferred shares (depositary receipts and foreign shares traded over the counter), over 6 quarters from 2024-12-31 to 2026-06-30, REGENERON PHARMACEUTICALS, INC. opened 0 positions, added to 0, reduced 0 and sold out of 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 872589), 6 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-07); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-08); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-06); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-07); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-01); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-02). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2024-12-31.

No position of this class changed this way in the filings compared.

Similar Firms

Firm NameCountry13F ValueHoldings
Portland Financial Advisors IncUnited States$0.048B77
Vickerman Investment Advisors, Inc.United States$0.048B94
Inflection Point Holdings II LLCUnited States$0.047B1
FLP Wealth Management, LLCUnited States$0.049B53
Capital CS Group, LLCUnited States$0.049B61
Global IMC LLCUnited States$0.047B16
ClearAlpha Technologies LPUnited States$0.049B74
PICKERING ENERGY PARTNERS LPUnited States$0.047B19
Firsthand Capital Management, Inc.United States$0.047B47
New Paradigm Capital Management, LLCUnited States$0.047B15